Related Experiment Video
Updated: Sep 15, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
LRRK2 kinase modulates glucose-stimulated insulin secretion via RAB8 phosphorylation and ciliogenesis
Nevia Dule1, Algerta Marku1, Alessandra Galli1
1Laboratory of Molecular and Cellular Physiology, Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Trentacoste 2, 20134, Milan, Italy.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) encodes a multidomain protein whose mutations have been identified as genetic risk factors for Parkinson's disease (PD), an age-related neurodegenerative disorder. Outside the nervous system, LRRK2 is expressed in multiple tissues, including the endocrine pancreas, but its role here is unknown. Using pharmacological and molecular approaches, we show that LRRK2 kinase activity regulates stimulated insulin secretion by influencing secretory granule trafficking. The PD-associated LRRK2 mutant G2019S, characterized by enhanced kinase activity, increases the basal insulin release in complementary in vitro models and affects the metabolic profile in transgenic mice. Mechanistically, we demonstrate that LRRK2 kinase activity influences the formation of the primary cilium, an antenna-like structure acting as signaling platform to regulate hormones secretion. Specifically, LRRK2 phosphorylates RAB8 in a glucose-dependent manner, facilitating its recruitment to the primary cilium. These findings identify LRRK2 as a regulator of insulin secretion in pancreatic β-cells. Given the role of insulin signaling and glucose homeostasis in the nervous system, our data suggest that LRRK2 may also contribute to PD development through peripheral action.
Insights
Leucine-rich repeat kinase 2 (LRRK2) influences insulin secretion in pancreatic cells. Mutations linked to Parkinson's disease affect this process, suggesting peripheral roles in neurodegeneration.
Area of Science:
- Endocrinology
- Neuroscience
- Cell Biology
Background:
- Leucine-rich repeat kinase 2 (LRRK2) mutations are genetic risk factors for Parkinson's disease (PD).
- LRRK2 is expressed in the endocrine pancreas, but its function there is unknown.
- Parkinson's disease is an age-related neurodegenerative disorder.
Purpose of the Study:
- To investigate the role of LRRK2 in pancreatic β-cell function.
- To determine if LRRK2 kinase activity regulates insulin secretion.
- To explore the mechanism by which LRRK2 influences hormone secretion.
Main Methods:
- Pharmacological inhibition and activation of LRRK2.
- Molecular approaches to study LRRK2 function.
- In vitro models of pancreatic β-cells.
- Transgenic mouse models with PD-associated LRRK2 mutations.
Main Results:
- LRRK2 kinase activity regulates stimulated insulin secretion by affecting secretory granule trafficking.
- The PD-associated G2019S LRRK2 mutant enhances basal insulin release.
- LRRK2 kinase activity influences primary cilium formation and RAB8 recruitment in a glucose-dependent manner.
Conclusions:
- LRRK2 is identified as a regulator of insulin secretion in pancreatic β-cells.
- LRRK2's role in peripheral insulin secretion may contribute to Parkinson's disease development.
- Dysregulation of LRRK2 in pancreatic cells could link metabolic dysfunction to neurodegeneration.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
11:31Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
cAMP-dependent Protein Kinase Pathways
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...